Results 81 to 90 of about 25,773 (228)
AimTo evaluate HBV quasispecies (QA) complexity in the preCore/Core regions in relation to HBeAg status, and explore QA changes under natural evolution and nucleoside analogue (NUC) treatment.MethodsUltra-deep pyrosequencing of HBV preCore/Core regions ...
Maria Homs +8 more
doaj +1 more source
Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
To elucidate the impact of a hepatitis B (HB) vaccination program on the prevalence of HB surface antigen (HBsAg) and HB envelope antigen (HBeAg) as well as the success rate of HBeAg clearance among parturients, we collected data on parturients who gave ...
Chen-Hsuan Wu +5 more
doaj +1 more source
Introduction: Hepatitis B virus (HBV) infection remains a significant global health challenge, annually contributing to approximately one million deaths from complications such as liver failure, cirrhosis, and hepatocellular carcinoma (HCC). Methods: This observational, descriptive, cross-sectional study was conducted at the Armed Forces Institute of ...
Dr. (Major) Samia Mahmood +3 more
openaire +1 more source
This graphical abstract illustrates the research workflow of natural polysaccharides, covering extraction approaches, deproteinization, depigmentation and purification procedures. Subsequent analyses include structural characterization, biological activity evaluation and structure‑activity relationship exploration to underpin polysaccharide research ...
Yian Zhao +7 more
wiley +1 more source
Background: As an uncommon serological pattern, the effect of hepatitis B e antigen/anti-hepatitis B e (HBeAg/anti-HBe) coexistence on peginterferon-α (Peg-IFN-α) therapy in patients with chronic hepatitis B (CHB) remains unknown.
Kaimin Song +9 more
doaj +1 more source
Background & Aims: The association between hepatitis B envelope antigen (HBeAg) seroclearance during long-term nucleos(t)ide analogue (NA) treatment and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) remains ...
Hyunjae Shin +12 more
doaj +1 more source
ABSTRACT Background Clinically significant CNS involvement by CLL/SLL is uncommon, diagnostically challenging, and has no established standard treatment. Case A 61‐year‐old man with previously untreated CLL/SLL was admitted in April 2023 to Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, with rapidly
Wei Xie +4 more
wiley +1 more source
Comparison of Ishak fibrosis scores between ALT 1–2×ULN and ALT >2×ULN in both HBeAg-positive and HBeAg-negative patients.
John Chi-Hang Yuen (310868) +7 more
core +1 more source
To describe the Hepatitis B e antigen(HBeAg) seroconversion related mutation profiles of the basal core promoter(BCP)/precore regions in e antigen seroconverted child patients, a cohort of 245 child patients with CHB and a control patients group of 92 ...
Yong Huang +7 more
doaj +1 more source
HBeAg negative chronic hepatitis B in South Asia
Chronic Hepatitis B (CHB) infection has an intermediate prevalence rate in South Asian countries, except for Nepal and Sri Lanka where it has a low rate. HBeAg negative CHB infection has been found to be more pronounced in this part of the world.
Ananta Shrestha +6 more
doaj +1 more source

